BridgeBio Pharma Inc (NAS:BBIO)
$ 27.94 0.18 (0.65%) Market Cap: 5.23 Bil Enterprise Value: 6.44 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 48/100

BridgeBio Pharma Inc Roundtable Discussion Transcript

Feb 16, 2023 / 05:00PM GMT
Release Date Price: $12.64 (+3.61%)
Operator

Good day, and thank you for standing by. Welcome to BridgeBio's Achondroplasia Educational Roundtable Event. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Dr. Neil Kumar, BridgeBio Founder and CEO. Please go ahead.

Neil Kumar
BridgeBio Pharma, Inc. - Co-Founder, President, CEO & Director

Thanks, operator. Appreciate the time, and I appreciate everyone taking the time today. We're privileged to spend the coming almost hour with Dr. Irving, who I'll introduce in a moment. The objectives of today's call in response to a bunch of questions that we've been getting from many of you over the past few months are simple and are really the following 4: number one, to better understand the unmet need associated with achondroplasia and related skeletal dysplasias; number two, to understand the path of mechanism of this disease as many of you know, this is a well-described disease; number three, within that context of understanding both the molecular path

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot